Clinical Trial Update: Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

An investigation using retinal cells derived from stem cells for myopic macular degeneration has been withdrawn (Phase 1/Phase 2; sponsor: UCLA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopic Macular Degeneration

Drugs mentioned

• Retinal cells derived from stem cells (Stem cell-derived retinal cells)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Myopic Macular Degeneration | Phase 1, Phase 2 | Status: WITHDRAWN